| Cavia porcellus |
Ileum |
Activity |
nan |
None |
10.1021/jm00229a014 |
| Cavia porcellus |
Muscarinic acetylcholine receptor M3 |
Contraction |
50.0 |
% |
10.1016/j.bmcl.2004.04.042 |
| Cavia porcellus |
Muscarinic acetylcholine receptor M3 |
Efficiency |
84.0 |
% |
10.1021/jm00079a002 |
| Cavia porcellus |
Muscarinic acetylcholine receptor M3 |
Intrinsic activity |
63.0 |
% |
10.1016/0960-894X(95)00301-9 |
| Cavia porcellus |
Muscarinic acetylcholine receptor M3 |
KA |
1.8 |
uM |
10.1016/0960-894X(95)00301-9 |
| Cavia porcellus |
Muscarinic acetylcholine receptor M3 |
pD2 |
5.9 |
None |
10.1021/jm00079a002 |
| Drosophila melanogaster |
Muscarinic acetylcholine receptor DM1 |
Ki |
2800.0 |
nM |
10.1021/jf0631934 |
| Drosophila melanogaster |
Muscarinic acetylcholine receptor DM1 |
Ki |
2980.0 |
nM |
10.1021/jf0631934 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
16107.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 2A13 |
Kd |
3000.0 |
nM |
10.1124/dmd.112.045161 |
| Homo sapiens |
Cytochrome P450 2A13 |
Ki |
1400.0 |
nM |
10.1124/dmd.112.045161 |
| Homo sapiens |
Cytochrome P450 2A6 |
Activity |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Kd |
3600.0 |
nM |
10.1124/dmd.112.045161 |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
3000.0 |
nM |
10.1124/dmd.112.045161 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
Relaxation |
nan |
None |
10.1016/j.bmcl.2004.04.042 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-37.85 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-2.28 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
3.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor |
ED50 |
1.0 |
uM |
10.1021/jm00126a030 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
38.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
1500.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Activity |
nan |
None |
10.1021/jm500860w |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
EC50 |
17.5 |
nM |
10.1016/j.bmcl.2015.02.012 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
EC50 |
812.83 |
nM |
10.1021/acs.jnatprod.2c01079 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
EC50 |
831.76 |
nM |
10.1021/jm500860w |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
EC50 |
8792.0 |
nM |
10.1016/s0960-894x(98)00509-5 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Efficacy |
102.0 |
% |
10.1016/j.bmcl.2015.02.012 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Emax |
65.0 |
% |
10.1021/acs.jnatprod.2c01079 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Emax |
69.0 |
% |
10.1021/jm500860w |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Kd |
2691.53 |
nM |
10.1021/jm500860w |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
6606.93 |
nM |
10.1016/j.bmc.2007.12.036 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
7943.28 |
nM |
10.1021/jm500860w |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Max PI |
27.0 |
% |
10.1016/s0960-894x(98)00509-5 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Max PI |
52.0 |
% |
10.1016/s0960-894x(98)00509-5 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
3802.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
15836.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
EC50 |
1000.0 |
nM |
10.1021/acs.jnatprod.2c01079 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
EC50 |
63000.0 |
nM |
10.1016/s0960-894x(98)00509-5 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Efficacy |
73.3 |
% |
10.1016/j.bmcl.2015.02.012 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Emax |
39.0 |
% |
10.1021/acs.jnatprod.2c01079 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
12022.64 |
nM |
10.1016/j.bmc.2007.12.036 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Max cAMP |
59.0 |
% |
10.1016/s0960-894x(98)00509-5 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ratio |
2.0 |
None |
10.1016/S0960-894X(01)80787-3 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
EC50 |
1445.44 |
nM |
10.1021/acs.jnatprod.2c01079 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Efficacy |
76.5 |
% |
10.1016/j.bmcl.2015.02.012 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Emax |
29.0 |
% |
10.1021/acs.jnatprod.2c01079 |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
EC50 |
3311.31 |
nM |
10.1021/acs.jnatprod.2c01079 |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Efficacy |
61.5 |
% |
10.1016/j.bmcl.2015.02.012 |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Emax |
26.0 |
% |
10.1021/acs.jnatprod.2c01079 |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
EC50 |
630.96 |
nM |
10.1021/acs.jnatprod.2c01079 |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Efficacy |
62.2 |
% |
10.1016/j.bmcl.2015.02.012 |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Emax |
34.0 |
% |
10.1021/acs.jnatprod.2c01079 |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
10232.93 |
nM |
10.1016/j.bmc.2007.12.036 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
4718.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
SK-N-SH |
PI turnover |
33.0 |
% |
10.1016/S0960-894X(01)80787-3 |
| Homo sapiens |
Solute carrier family 22 member 1 |
Inhibition |
17.0 |
% |
10.1021/jm8003152 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Musca domestica |
Musca domestica |
Activity |
0.0 |
% |
10.1021/jf0631934 |
| Musca domestica |
Musca domestica |
Activity |
3.0 |
% |
10.1021/jf0631934 |
| Musca domestica |
Musca domestica |
Activity |
7.0 |
% |
10.1021/jf0631934 |
| Musca domestica |
Musca domestica |
Activity |
10.0 |
% |
10.1021/jf0631934 |
| Musca domestica |
Musca domestica |
Activity |
23.0 |
% |
10.1021/jf0631934 |
| Musca domestica |
Musca domestica |
Activity |
67.0 |
% |
10.1021/jf0631934 |
| Mus musculus |
Muscarinic acetylcholine receptor M1 |
EC50 |
6900.0 |
nM |
10.1021/jm960467d |
| Mus musculus |
Muscarinic acetylcholine receptor M1 |
Smax |
150.0 |
% |
10.1021/jm960467d |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/ml300372f |
| Mus musculus |
Mus musculus |
ED50 |
3.87 |
mg.kg-1 |
10.1021/jm981048e |
| Mus musculus |
Mus musculus |
ED50 |
4.0 |
mg.kg-1 |
10.1021/jm981048e |
| Mus musculus |
Mus musculus |
ED50 |
10.0 |
mg.kg-1 |
10.1021/jm981048e |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor |
Efficiency |
100.0 |
% |
10.1021/jm00079a002 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor |
Efficiency |
130.0 |
% |
10.1021/jm00079a002 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor |
IC50 |
68.0 |
nM |
10.1016/s0960-894x(98)00509-5 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor |
IC50 |
80.0 |
nM |
10.1021/jm00079a002 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor |
IC50 |
7600.0 |
nM |
10.1016/S0960-894X(00)80531-4 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor |
IC50 |
7600.0 |
nM |
10.1021/jm00059a008 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor |
K app |
0.04 |
uM |
10.1021/jm00080a014 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor |
K app |
0.04 |
uM |
10.1021/jm00166a008 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor |
K app |
0.04 |
uM |
10.1021/jm00172a003 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor |
K app |
4.0 |
uM |
10.1021/jm00080a014 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor |
K app |
4.0 |
uM |
10.1021/jm00166a008 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor |
K app |
4.0 |
uM |
10.1021/jm00172a003 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor |
Ki |
82.9 |
nM |
10.1021/jm00115a003 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor |
Ki |
1010.0 |
nM |
10.1021/jm00115a003 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor |
Ki |
1110.0 |
nM |
10.1021/jm00115a003 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor |
Ki |
3670.0 |
nM |
10.1021/jm00009a016 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor |
Max stimulation |
37.0 |
% |
10.1021/jm00009a016 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor |
Ratio |
100.0 |
None |
10.1021/jm00080a014 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor |
Ratio |
100.0 |
None |
10.1021/jm00166a008 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor |
Ratio |
100.0 |
None |
10.1021/jm00172a003 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor |
Ratio |
141.0 |
None |
10.1021/jm00009a016 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
IC50 |
960.0 |
nM |
10.1021/jm00079a002 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
IC50 |
4430.0 |
nM |
10.1016/S0960-894X(01)80787-3 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
Intrinsic activity |
37.0 |
% |
10.1016/0960-894X(95)00301-9 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
Ki |
3100.0 |
nM |
10.1016/0960-894X(95)00301-9 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
pD2 |
5.6 |
None |
10.1021/jm00079a002 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
pD2 |
6.5 |
None |
10.1021/jm00079a002 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
Ratio |
12.0 |
None |
10.1021/jm00079a002 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M2 |
IC50 |
8800.0 |
nM |
10.1016/S0960-894X(01)80787-3 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M2 |
Intrinsic activity |
48.0 |
% |
10.1016/0960-894X(95)00301-9 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M2 |
Kd |
10000.0 |
nM |
10.1021/jm00079a002 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M2 |
Ki |
9800.0 |
nM |
10.1016/0960-894X(95)00301-9 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
58.0 |
% |
10.1021/jm960467d |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1021/jm981048e |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
4.5 |
mg.kg-1 |
10.1021/jm981048e |
| Rattus norvegicus |
Rattus norvegicus |
PI |
58.0 |
% |
10.1021/jm00059a008 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Voltage-gated N-type calcium channel alpha-1B subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
MIC |
200000.0 |
nM |
10.1016/j.ejmech.2011.10.053 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
MIC50 |
nan |
None |
10.1016/j.ejmech.2011.10.053 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.1136 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| None |
ADMET |
Binding energy |
10.1 |
kCal mol-1 |
10.1021/jm00378a021 |
| None |
ADMET |
Ratio |
0.83 |
None |
10.1124/dmd.112.045161 |
| None |
ADMET |
Ratio Ki |
0.47 |
None |
10.1124/dmd.112.045161 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Active |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Marginal |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx1000865 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1124/dmd.110.035113 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
4.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LDH Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Index Value |
4.6 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Index Value |
4.6 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
No relevant target |
LogD |
-0.15 |
None |
10.1021/jm00146a001 |
| None |
No relevant target |
LogD7.4 |
-0.37 |
None |
10.6019/CHEMBL3301361 |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1080/15376510701857262 |
| None |
Unchecked |
Ac50 |
0.7079 |
uM |
None |
| None |
Unchecked |
Ac50 |
7.943 |
uM |
None |
| None |
Unchecked |
Ac50 |
10.0 |
uM |
None |
| None |
Unchecked |
Ac50 |
12.59 |
uM |
None |
| None |
Unchecked |
Ac50 |
22.39 |
uM |
None |
| None |
Unchecked |
AC50 |
707.9 |
nM |
None |
| None |
Unchecked |
AC50 |
7950.0 |
nM |
None |
| None |
Unchecked |
AC50 |
10000.0 |
nM |
None |
| None |
Unchecked |
AC50 |
12589.3 |
nM |
None |
| None |
Unchecked |
AC50 |
22387.2 |
nM |
None |
| None |
Unchecked |
IC50 |
67.0 |
nM |
10.1021/jm981048e |
| None |
Unchecked |
IC50 |
7600.0 |
nM |
10.1021/jm960467d |
| None |
Unchecked |
IC50 |
10000.0 |
nM |
None |
| None |
Unchecked |
Ki |
26.0 |
nM |
10.1021/jm00009a016 |
| None |
Unchecked |
Potency ratio |
7.0 |
None |
10.1016/s0960-894x(98)00509-5 |
| None |
Unchecked |
Ratio |
142.0 |
None |
10.1016/S0960-894X(01)80787-3 |